← back to search

Yousra Kherabi

Université Claude Bernard Lyon 1 · FR
🔎 Find collaborators in Infectious Diseases · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Medicine, Tuberculosis, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak, and Bedaquiline.
h-index
citations
1,279
works
14
NIH funding
primary concept
email

Recent publications

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis
The Lancet Infectious Diseases 2025cited by 10position: middledoi
Post-TB Lung Disease: Where are we to Respond to This Priority?
Archivos de Bronconeumología 2025cited by 10position: middledoi
Beyond a cure for TB: confronting the hidden burden of post-TB lung disease
IJTLD OPEN 2025cited by 10position: firstdoi
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study
The Lancet Regional Health - Europe 2025cited by 10position: firstdoi
Clinical standards for antimicrobial stewardship in TB care
IJTLD OPEN 2025cited by 2position: middledoi
Machine learning to predict antimicrobial resistance: future applications in clinical practice?
Infectious Diseases Now 2024cited by 21position: firstdoi
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe
Clinical Microbiology and Infection 2024cited by 20position: middledoi
Recent advances in the treatment of tuberculosis
Clinical Microbiology and Infection 2023cited by 110position: middledoi
Epidemiology of Mycobacterium abscessus
Clinical Microbiology and Infection 2023cited by 52position: middledoi
Machine learning approaches in diagnosing tuberculosis through biomarkers - A systematic review
Progress in Biophysics and Molecular Biology 2023cited by 29position: middledoi
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Clinical Microbiology and Infection 2021cited by 945position: middledoi
COVID-19 vaccine boosters: What do we know so far?
Anaesthesia Critical Care & Pain Medicine 2021cited by 22position: firstdoi
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern
2021cited by 21position: middledoi
COVID-19 vaccines: A race against time
Anaesthesia Critical Care & Pain Medicine 2021cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nathan Peiffer‐Smadja · Inserm5 papers (2021–2024)Lorenzo Guglielmetti · Ospedale Sacro Cuore Don Calabria3 papers (2023–2025)Gunar Günther · University of Bern3 papers (2023–2025) · 3 papers (2021–2021)Christoph Lange · Médecins Sans Frontières3 papers (2023–2025)Jade Ghosn · Délégation Paris 52 papers (2021–2021)Lia D’Ambrosio · McGill University Health Centre2 papers (2025–2025) · 2 papers (2025–2025)Giovanni Battista Migliori · University of Cape Town2 papers (2025–2025)Dumitru Chesov · Phthisiopneumology Institute "Chiril Draganiuc"2 papers (2023–2025)Sacha Rozencwajg · Université Claude Bernard Lyon 12 papers (2021–2021)Guy Thwaites · University of Oxford1 papers (2023–2023) · 1 papers (2021–2021)Helen McIlleron · University of Cape Town1 papers (2023–2023)Reinout van Crevel · Andrews University1 papers (2023–2023)Robert J. Wilkinson · South African Medical Research Council1 papers (2023–2023) · 1 papers (2025–2025) · 1 papers (2023–2023) · 1 papers (2025–2025)Zarir Udwadia · Fudan University1 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Epidemiology →